Mgi Tech Co., Ltd. (688114.SH) announced that its wholly-owned subsidiary, Shenzhen Mgi Tech Bioelectronics Co., Ltd., has recently obtained a Medical Device Registration Certificate from the People's Republic of China for its gene sequencing instrument. The product utilizes Combinatorial Probe-Anchor Synthesis sequencing technology and is clinically intended for sequencing DNA and RNA derived from human samples to detect gene sequences. These sequences can be used to assist in the diagnosis of diseases or disease susceptibility. The instrument is clinically limited to use in conjunction with in vitro diagnostic reagents and software approved by the National Medical Products Administration and is not intended for whole human genome sequencing or de novo sequencing.